(Q39387112)

11 September 2017

title

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma (English)

1 reference

11 September 2017

11

1 reference

11 September 2017

Graham J Mann

12

0 references

Adrian C. Herington

Adrian Herington

14

0 references

Lauren Aoude

Lauren G Aoude

4

0 references

Christopher W. Schmidt

Christopher W Schmidt

13

0 references

Nicholas Hayward

Nicholas K Hayward

15

0 references

Ken Dutton-Regester

1

Ken Dutton-Regester

1 reference

11 September 2017

7

Cathy Lanagan

1 reference

11 September 2017

5

Varsha Tembe

1 reference

11 September 2017

6

Gulietta M Pupo

1 reference

11 September 2017

Darryl Irwin

2

1 reference

11 September 2017

Priscilla Hunt

3

1 reference

11 September 2017

Candace D Carter

8

1 reference

11 September 2017

Linda O'Connor

9

1 reference

11 September 2017

Michael O'Rourke

10

1 reference

11 September 2017

publication date

1 March 2012

1 reference

Molecular Cancer Therapeutics

11 September 2017

published in

1 reference

11 September 2017

volume

11

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

888-897

1 reference

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

11 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1158/1535-7163.MCT-11-0676

1 reference

11 September 2017

1 reference